Southeast Dermatology Specialists

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Chronic spontaneous urticaria1 trial
• Psoriasis1 trial

Phase

• Phase 32 trials

Status

• Active, not recruiting2 trials

Lead sponsor

• Janssen Research & Development, LLC1 trial
• Novartis Pharmaceuticals1 trial

Running trials

• Active, not recruiting

  A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines

  NCT06868212· Phase 3· Novartis Pharmaceuticals· Source

• Active, not recruiting

  A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis (ICONIC-ADVANCE 2)

  NCT06220604· Phase 3· Janssen Research & Development, LLC· Source